Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway’s 13F stock portfolio on a quarterly basis. It is based on Warren Buffett’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking 10 Years Of Berkshire Hat...
As expected , the market has moved from indiscriminate buying to stock picking. Following its rapid oversold rally, the SPDR S&P 500 ETF ( SPY ) has made little headway over the past month. Instead, investors have begun separating long-term winners from losers, resulting in significant ou...
For Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) shareholders and fans of Warren Buffett , the previous weekend was the most-anticipated event of the year. On Saturday, May 2, Buffett held his company's annual shareholder meeting (albeit virtually) and provided the usual dose of long-te...
Dialysis is the process of using a medical circulation device (either at home or at a clinic) to substitute kidney functions for patients with end-stage kidney failure. Each year, over 100,000 Americans with new cases of renal failure visit dialysis clinics to receive appropriate treatment. The ...
DENVER , May 7, 2020 /PRNewswire/ -- DaVita Kidney Care recently announced its continued support for U.S. employees, known as teammates, during the COVID-19 pandemic by implementing and strengthening programs specifically created to meet the emerging needs of teammates based on t...
Image source: The Motley Fool. DaVita (NYSE: DVA) Q1 2020 Earnings Call May 05, 2020 , 5:00 p.m. ET Operator Continue reading
DaVita Inc. (DVA) Q1 2020 Earnings Conference Call May 5, 2020 5:00 PM ET Company Participants Jim Gustafson – Vice President of Investor Relations Javier Rodriguez – Chief Executive Officer Joel Ackerman – Chief Financial Officer Conference Call Participa...
DaVita (NYSE: DVA ) Q1 results : More news on: DaVita Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...
DaVita HealthCare Partners (NYSE: DVA ): Q1 Non-GAAP EPS of $1.83 beats by $0.35 ; GAAP EPS of $1.81 beats by $0.32 . Revenue of $2.84B (+3.6% Y/Y) in-line. Press Release More news on: DaVita Inc., Earnings news and commentary, Healthcare stocks news,
DENVER , May 5, 2020 /PRNewswire/ -- During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its patients whose lives depend on receiving dialysis treatm...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...